郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价NS383 Selectively Inhibits Acid-Sensing Ion Channels Containing 1a and 3 Subunits to Reverse Inflammatory and Neuropathic Hyperalgesia in Rats.

期刊：CNS neuroscience & therapeutics发表年份：2016作者：Gordon Munro; Jeppe K Christensen; Helle K Erichsen; Tino Dyhring; Joachim Demnitz; Eva Dam; Philip K Ahring
阅读更多 →

药效评价Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.

期刊：The Biochemical journal发表年份：2016作者：Alexandra D Kharlamova; Sofya V Lushchekina; Konstantin A Petrov; Ekaterina D Kots; Florian Nachon; Marielle Villard-Wandhammer; Irina V Zueva; Eric Krejci; Vladimir S Reznik; Vladimir V Zobov; Evgeny E Nikolsky; Patrick Masson
阅读更多 →

药效评价Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.

期刊：Journal of neurochemistry发表年份：2016作者：Roger Slavik; Adrienne Müller Herde; Achi Haider; Stefanie D Krämer; Markus Weber; Roger Schibli; Simon M Ametamey; Linjing Mu
阅读更多 →

药效评价Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.

期刊：Molecular pharmacology发表年份：2016作者：Alice E Berizzi; Patrick R Gentry; Patricia Rueda; Sandra Den Hoedt; Patrick M Sexton; Christopher J Langmead; Arthur Christopoulos
阅读更多 →